Northwire Canada EditionThursday, July 16, 2026
Northwire
FCI 0.380 +0.0% GGAU 0.190 +0.0% KIRO 0.640 +0.0% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.100 +0.0% SHL 0.360 +1.4% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.46 +0.2% CAM 0.330 −1.5% SYH 0.405 +0.0% LOT 0.035 −12.5% CPL 0.180 −5.3% OTMC 0.400 +0.0% FCI 0.380 +0.0% GGAU 0.190 +0.0% KIRO 0.640 +0.0% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.100 +0.0% SHL 0.360 +1.4% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.46 +0.2% CAM 0.330 −1.5% SYH 0.405 +0.0% LOT 0.035 −12.5% CPL 0.180 −5.3% OTMC 0.400 +0.0%
Management

DelphX Capital Markets Inc. and Belgravia Hartford Capital Inc. Announce Non-Binding Letter of Intent for First Quantem Crypto Security Transaction, and DelphX Announces CFO Transition and Grant of Options

DELX · Price

Executive Summary

  • DelphX Capital Markets entered into a non‑binding LOI with Belgravia Hartford Capital to pursue the first commercial Quantem Crypto Security (“QCS”) transaction, which would involve a corporate purchase of a QCS collateralized put option protecting Bitcoin treasury holdings.
  • The company announced a CFO transition: Bill Hahn will depart; Simon Selkrig returns as CFO effective 1 Jan 2026.
  • The Board approved the grant of 2,875,000 stock options at an $0.08 exercise price, each with a two‑year maturity.

Key Details

  • LOI Scope: Collaboration on the first commercial QCS transaction; Belgravia to be the inaugural corporate purchaser of a QCS collateralized put option.
  • Conditions: Transaction subject to definitive agreements, regulatory approvals, market conditions, and customary closing conditions; LOI is non‑binding except for confidentiality, compliance, and disclosure provisions.
  • Advisory Role: Belgravia will provide advisory and structuring support, including program documentation, compliance processes, and coordination with the placement agent.
  • CFO Change: Bill Hahn resigns as CFO to pursue another opportunity; Simon Selkrig re‑appointed as CFO effective 1 Jan 2026.
  • Stock Option Grant: Board approved 2,875,000 options under the company’s stock option plan; two‑year maturity; exercise price $0.08 per common share.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from DelphX Capital Markets Inc.